診斷領域經銷協議（2016-2026）

本報告調查並分析了全球診斷領域的分銷合作關係，詳細闡述了企業如何制定分銷協議、協商財務條款以及透過策略合作拓展市場。

目錄

摘要整理

第一章：引言

第二章：分銷合約趨勢

• 引言
• 分銷合約的定義
• 分銷合約趨勢（2016年至今）
  • 經銷合約：依年份
  • 分銷合約：依研發階段
  • 分銷合約：依治療領域
  • 分銷合約：依技術
  • 最活躍公司的分銷合約
  • 純分銷合約的特點
  • 多組件合約中的分銷特點
• 透過合作使分銷合約有效運作

第三章：分銷合約概述架構

• 引言
• 分銷合約結構
• 分銷權是更廣泛的合作研究協議的一部分

第四章：主要分銷合約

• 引言
• 依價值排名的頂級分銷合約

第五章：最活躍的25家經銷合約公司

• 引言
• 最活躍的25家分銷合約公司

第六章：分銷合約（含合約目錄）

• 引言
• 包含書面協議的分銷合約
• 合約目錄
• 合約目錄 - 分銷合約：依公司（A-Z）分類
• 合約目錄 - 經銷合約：依治療領域分類
• 合約目錄 - 分銷合約：依技術類型分類
• 生物製藥研究股份有限公司簡介
• 當前合作夥伴
• 當前協議
• 現任合作夥伴近期報告標題

Benchmark Distribution Partnerships Across the Global Diagnostics Industry

This latest Distribution Deals in Diagnostics report provides a comprehensive analysis of distribution partnerships across the diagnostics sector. Designed for business development, licensing, and commercial strategy professionals, the report delivers detailed insight into how companies structure distribution agreements, negotiate financial terms, and expand market access through strategic partnerships.

Fully revised and updated, the report analyzes distribution deals announced between 2016 and 2026, providing a clear view of how diagnostics companies establish commercial distribution channels and global market coverage.

The report contains a comprehensive directory of distribution deals recorded in the Current Agreements database, including financial information where available and links to online deal records. Where agreements have been publicly filed, the report also provides direct access to the underlying contract documents submitted to the SEC, enabling deeper insight into the terms negotiated between partners.

Whether you are benchmarking deal structures, evaluating potential distribution partners, or conducting due diligence on commercialization strategies, this report provides the real-world deal data and contract visibility needed to structure stronger distribution partnerships.

Key Benefits

• Save Significant Research Time

Access a consolidated resource of distribution deals instead of searching multiple press releases, databases, and regulatory filings.

• Benchmark Distribution Deal Structures

Understand how diagnostics companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.

• Analyze Financial Deal Terms

Review disclosed payment terms and commercial arrangements to benchmark the financial structure of comparable distribution agreements.

• Access Real Contract Documents

Where available, explore SEC-filed distribution agreements, providing insight into detailed contractual provisions that are rarely disclosed publicly.

• Identify the Most Active Distribution Dealmakers

Discover which companies are leading distribution partnerships across the diagnostics sector.

• Track Industry Trends

Analyze distribution dealmaking trends since 2016 to understand how commercialization strategies are evolving across diagnostics technologies and markets.

What's Included in the Report

Analysis of distribution dealmaking trends since 2016

Overview of distribution deal structures and commercial models

Review of leading distribution deals by headline value

Profiles of the most active distribution dealmakers

Detailed analysis of deals organized by company, technology type, and therapeutic focus

A comprehensive directory of distribution deals recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual distribution contracts, the report allows users to evaluate key partnership provisions such as:

• Territorial distribution rights
• Commercial responsibilities between partners
• Payment structures and financial terms
• Exclusivity provisions
• Supply and commercialization obligations
• Contract duration and termination provisions
• Why This Report Matters
• Distribution partnerships play a critical role in enabling diagnostics companies to expand global reach, accelerate product commercialization, and access new healthcare markets.
• By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to structure stronger distribution partnerships and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by therapy area
  • 2.3.4. Distribution dealmaking by technology type
  • 2.3.5. Distribution dealmaking by most active company
  • 2.3.6 Attributes of pure distribution deals
  • 2.3.7 Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3 Distribution rights part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers

Chapter 6 - Distribution deals including contracts directory

• 6.1. Introduction
• 6.2. Distribution deals with contracts
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by therapy area
• Figure 5: Distribution deals by technology type
• Figure 6: Top 25 most active distribution dealmakers
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value
• Figure 11: Most active distribution dealmakers